Int J Obes (Lond) 2010;34:38595
The service includes unlimited professional consultations, regular check-ins to address challenges like plateaus, and adjustments to treatment plans as needed
Some researchers, especially those with higher body weight or prior GLP-1 exposure, may not notice any appetite or metabolic changes at 2mg
Factors that may influence perioperative management include: Medication characteristics : Daily GLP-1 medications (liraglutide, oral semaglutide) have shorter durations of action than weekly formulations (injectable semaglutide, dulaglutide, exenatide extended-release) [3] Risk factors : Higher doses, recent dose increases, active gastrointestinal symptoms, or known gastroparesis may increase risk [1] [3] Procedure type : More complex surgeries or those requiring general anaesthesia may warrant different approaches than minor procedures Individual patient factors : BMI, presence of diabetes, and other medical conditions Some anaesthetists may recommend temporarily pausing GLP-1 therapy before certain procedures, particularly for patients with additional risk factors
